Literature DB >> 31536441

Implementation of Single-Tab Electrodes for Bioimpedance Spectroscopy Measures.

Paula M C Donahue1,2, Rachelle Crescenzi3, Liping Du4,5, Manus J Donahue3,6,7.   

Abstract

Background: Bioimpedance spectroscopy (BIS) demonstrates proficiency in early identification of breast cancer treatment-related lymphedema (BCRL) development. Dual-tab electrodes were designed for consistent and easy electrode placement, however, single-tab electrodes positioned to mimic dual-tab placement on the body may make BIS technology more accessible in community hospitals and outpatient settings. The purpose of this study is to evaluate use of single-tab electrodes for BIS measurements and assess whether single-tab electrodes provide consistent BIS measurements in controls and patients with BCRL. Methods and
Results: Upper limb BIS ratios were obtained using ImpediMed L-Dex® U400 in controls (n = 13; age = 23-75 years; 9 repeated measurements) using dual-tab and single-tab electrodes. BCRL patients (n = 17; Stage = 1.65 ± 0.49; number nodes removed = 16.3 ± 7.7; age = 50.9 ± 10.6 years; age range = 33-77 years) and healthy controls (n = 19) were evaluated to determine if single-tab electrodes provided discriminatory capacity for detecting BCRL. Intraclass correlation coefficients (ICC), linear mixed-effects models, Wilcoxon rank-sum tests, and linear regression with two-sided p-values <0.05 required for significance were applied. Single-tab electrodes were found to be statistically interchangeable with dual-tab electrodes (ICC = 0.966; 95% confidence interval = 0.937-0.982). No evidence of differences in single-tab versus dual-tab measurements were found for L-Dex ratios (p = 0.74) from the linear mixed-effects model. Repeated trials involving reuse of the same electrodes revealed a trend toward increases in L-Dex ratio for both styles of electrodes. Single-tab electrodes were significant (p < 0.0001) for discriminating between BCRL and control subjects.
Conclusion: Findings expand upon the potential use of BIS in clinic and research settings and suggest that readily available single-tab electrodes provide similar results as dual-tab electrodes for BIS measurements.

Entities:  

Keywords:  L-Dex; bioimpedance spectroscopy; breast cancer treatment-related lymphedema; electrodes; lymphedema; physical therapy

Year:  2019        PMID: 31536441      PMCID: PMC7310215          DOI: 10.1089/lrb.2019.0035

Source DB:  PubMed          Journal:  Lymphat Res Biol        ISSN: 1539-6851            Impact factor:   2.589


  22 in total

1.  Operational equivalence of bioimpedance indices and perometry for the assessment of unilateral arm lymphedema.

Authors:  Leigh C Ward; Sharon Czerniec; Sharon L Kilbreath
Journal:  Lymphat Res Biol       Date:  2009       Impact factor: 2.589

2.  Confirmation of the reference impedance ratios used for assessment of breast cancer-related lymphedema by bioelectrical impedance spectroscopy.

Authors:  L C Ward; E Dylke; S Czerniec; E Isenring; S L Kilbreath
Journal:  Lymphat Res Biol       Date:  2011-03       Impact factor: 2.589

3.  L-dex ratio in detecting breast cancer-related lymphedema: reliability, sensitivity, and specificity.

Authors:  M R Fu; C M Cleland; A A Guth; M Kayal; J Haber; F Cartwright; R Kleinman; Y Kang; J Scagliola; D Axelrod
Journal:  Lymphology       Date:  2013-06       Impact factor: 1.286

Review 4.  Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis.

Authors:  Tracey DiSipio; Sheree Rye; Beth Newman; Sandi Hayes
Journal:  Lancet Oncol       Date:  2013-03-27       Impact factor: 41.316

5.  A pilot randomized trial evaluating lymphedema self-measurement with bioelectrical impedance, self-care adherence, and health outcomes.

Authors:  Sheila H Ridner; Ya-Chen Tina Shih; Jennifer K Doersam; Bethany Andrews Rhoten; Benjamin S Schultze; Mary S Dietrich
Journal:  Lymphat Res Biol       Date:  2014-12       Impact factor: 2.589

6.  A Prospective Validation Study of Bioimpedance with Volume Displacement in Early-Stage Breast Cancer Patients at Risk for Lymphedema.

Authors:  Andrea V Barrio; Anne Eaton; Thomas G Frazier
Journal:  Ann Surg Oncol       Date:  2015-06-18       Impact factor: 5.344

Review 7.  Breast-cancer related lymphedema: a review of procedure-specific incidence rates, clinical assessment AIDS, treatment paradigms, and risk reduction.

Authors:  Chirag Shah; Douglas Arthur; Justin Riutta; Pat Whitworth; Frank A Vicini
Journal:  Breast J       Date:  2012 Jul-Aug       Impact factor: 2.431

8.  Bioelectrical impedance for detecting upper limb lymphedema in nonlaboratory settings.

Authors:  Sheila H Ridner; Mary S Dietrich; Jie Deng; Candace M Bonner; Nancy Kidd
Journal:  Lymphat Res Biol       Date:  2009       Impact factor: 2.589

9.  Comparison of methods to diagnose lymphoedema among breast cancer survivors: 6-month follow-up.

Authors:  Sandi Hayes; Bruce Cornish; Beth Newman
Journal:  Breast Cancer Res Treat       Date:  2005-02       Impact factor: 4.872

Review 10.  An early warning surveillance programme for detecting upper limb deterioration after treatment for breast cancer: A novel technology supported system.

Authors:  Delva Shamley; Karen Robb
Journal:  BMC Cancer       Date:  2015-09-15       Impact factor: 4.430

View more
  1 in total

1.  Magnetic resonance imaging and bioimpedance evaluation of lymphatic abnormalities in patients with breast cancer treatment-related lymphedema.

Authors:  Paula M C Donahue; Rachelle Crescenzi; Chelsea Lee; Maria Garza; Niral J Patel; Kalen J Petersen; Manus J Donahue
Journal:  Breast Cancer Res Treat       Date:  2020-06-29       Impact factor: 4.872

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.